How can Biology of Aging Explain the Severity of COVID-19 in Older Adults
- PMID: 35868666
- PMCID: PMC9023334
- DOI: 10.1016/j.cger.2022.04.002
How can Biology of Aging Explain the Severity of COVID-19 in Older Adults
Abstract
Aging has been identified as one of the most relevant risk factors for poor outcomes in COVID-19 infection. Since now, different mechanisms responsible for worse outcomes in the elderly have been proposed, which include the remodeling of immune system, the higher prevalence of malnutrition and sarcopenia, the increased burden of multimorbidity, and, to a lesser extent, the direct effects of age on the respiratory system and hormonal profile. It seems that the interplay between all these causes, rather than the individual pathophysiological mechanism, explains the increased severity of the disease with age.
Keywords: Aging; COVID-19; Comorbidities; Immunosenescence; Inflammaging; Malnutrition; Sarcopenia.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Immunosenescence and COVID-19.Mech Ageing Dev. 2022 Jun;204:111672. doi: 10.1016/j.mad.2022.111672. Epub 2022 Apr 1. Mech Ageing Dev. 2022. PMID: 35378106 Free PMC article. Review.
-
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People.Front Immunol. 2020 Oct 27;11:579220. doi: 10.3389/fimmu.2020.579220. eCollection 2020. Front Immunol. 2020. PMID: 33193377 Free PMC article. Review.
-
Immunosenescence, Inflammaging and Resilience: An Evolutionary Perspective of Adaptation in the Light of COVID-19 Pandemic.Psychiatr Danub. 2021 Spring-Summer;33(Suppl 4):427-431. Psychiatr Danub. 2021. PMID: 34718260
-
Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?Ageing Res Rev. 2021 Nov;71:101422. doi: 10.1016/j.arr.2021.101422. Epub 2021 Aug 13. Ageing Res Rev. 2021. PMID: 34391943 Review.
-
Immunosenescence and Inflammaging in COVID-19.Viral Immunol. 2023 Nov;36(9):579-592. doi: 10.1089/vim.2023.0045. Epub 2023 Oct 5. Viral Immunol. 2023. PMID: 37797216 Review.
Cited by
-
Relationship between multimorbidity, SARS-COV-2 infection and long COVID: a cross-sectional population-based French survey.BMC Med. 2025 Apr 15;23(1):222. doi: 10.1186/s12916-025-04027-9. BMC Med. 2025. PMID: 40234933 Free PMC article.
-
Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniques.Sci Rep. 2025 Mar 19;15(1):9459. doi: 10.1038/s41598-025-85733-5. Sci Rep. 2025. PMID: 40108236 Free PMC article.
-
Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers.J Infect Public Health. 2023 Mar;16(3):384-392. doi: 10.1016/j.jiph.2023.01.016. Epub 2023 Jan 21. J Infect Public Health. 2023. PMID: 36702013 Free PMC article.
-
The Function of Memory CD8+ T Cells in Immunotherapy for Human Diseases.Immune Netw. 2023 Feb 23;23(1):e10. doi: 10.4110/in.2023.23.e10. eCollection 2023 Feb. Immune Netw. 2023. PMID: 36911798 Free PMC article. Review.
-
Multimorbidity and SARS-CoV-2-Related Outcomes: Analysis of a Cohort of Italian Patients.JMIR Public Health Surveill. 2023 Feb 9;9:e41404. doi: 10.2196/41404. JMIR Public Health Surveill. 2023. PMID: 36626821 Free PMC article.
References
-
- WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/director-general/speeches/detail/ Available at: Accessed February 11, 2020.
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for disease control and prevention. JAMA. 2020;323(13):1239–1242. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical